The rapid evolution of proteomics has continued during the past year, with
a series of innovations in the core technologies of two-dimensional electro
phoresis and mass spectrometry, and a diversity of productive research prog
rammes. Well-annotated proteomics databases are now emerging in a number of
fields to provide a platform for systematic research, with particularly pr
omising progress in clinical applications such as cardiology and oncology.
Large-scale quantitative research, comparable in power and sensitivity to t
hat achieved for gene expression, is thus becoming a reality at the protein
level.